PIEZO1 and breast cancer: When comparing Caucasian patients (White) with African American patients (Black) with HR-negative breast cancer, interestingly, our results demonstrated that Black patients had higher PIEZO1 expression levels than White patients (p = 0.002) (Figure S7A).